Eledon Pharmaceuticals, Inc.

Ownership Transactions Reported by 13 Insiders

Symbol
ELDN on Nasdaq
Location
19800 Macarthur Blvd., Suite 250, Irvine, CA

There are no Buy or Sell transactions made by insiders since 10/5/2023

Eledon Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Keith Katkin Director $1.17M May 1, 2023
David-Alexandre C. Gros Chief Executive Officer, Director $802K Jun 13, 2024
Steven Perrin President, Director $664K Jun 13, 2024
Bvf Partners L P/Il 10%+ Owner $573K May 9, 2024
Gary A. Lyons Director $422K May 1, 2023
Paul Little Chief Financial Officer $415K Jun 13, 2024
Bryan Smith General Counsel, Corporate Sec $375K Jun 13, 2024
Walter Ogier Director $233K May 1, 2023
James A. Robinson Jr. Director $233K Oct 2, 2023
Jan Hillson Director $233K May 1, 2023
June Lee Director $233K May 1, 2023
John McBride Director $233K May 1, 2023
Allan Kirk Director $233K Oct 2, 2023

Recent Insider Transactions by Companies or Individuals for Eledon Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.